Spots Global Cancer Trial Database for Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
Official Title: An Open Label, Multicentre, Single Arm Trial to Assess the Safety of Afatinib for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
Study ID: NCT01953913
Conditions
Interventions
Study Description
Brief Summary: Primary objective of the trial is to evaluate the safety of afatinib in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR (Epidermal growth factor receptor) mutation(s) and have never been treated with an EGFR-TKI (tyrosine kinase inhibitor). Secondary objective is to assess the time to symptomatic progression (as judged by investigator).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
307 Hospital of PLA, Beijing, , China
Beijing Cancer Hospital, Beijing, , China
Chinese PLA General Hospital, Beijing, , China
Jilin Province Cancer Hospital, Changchun, , China
Guangdong Provincial People's Hospital, Guangzhou, , China
Zhejiang Cancer Hospital, Hangzhou, , China
Lin Yi Tumor Hospital, Linyi, , China
Jiangsu Cancer Hospital, Nanjing, , China
Shanghai Chest Hospital, Shanghai, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
Shanghai Pulmonary Hospital, Shanghai, , China
Tianjin Medical University Cancer Institute and Hospital, Tianjin, , China
Queen Mary Hospital, Hong Kong, , Hong Kong
Prince of Wales Hospital, Shatin, , Hong Kong
Vikram Hospital, Bangalore, , India
HCG Hospital, Bengaluru, , India
P VS Hospital Pvt Ltd, Calicut, , India
V S Hospital, Chennai, , India
Max Super Speciality Hospital, Delhi, Delhi, , India
Global Hospitals, Hyderabad, , India
Basavatarakam Indo - American Cancer Hospital & Research Ins, Hyderabad, , India
SEAROC Cancer Centre, Jaipur, , India
B. P. Poddar Hospital & Medial Research Ltd, Kolkata,West Bengal, , India
Asirvatham Multispeciality Hospital, Madurai, , India
Curie Manavata Cancer Centre, Maharashtra, , India
Shatabdi Superspeciality Hospital, Maharashtra, , India
Prince Aly Khan Hospital, Mumbai, , India
Ruby Hall Clinic, Pune, , India
National Cancer Centre, Singapore, , Singapore
E-Da Hospital, Kaohsiung, , Taiwan
NCKUH, Tainan, , Taiwan
Tri-Service General Hospital, Taipei, , Taiwan
Chang-Gung Memorial Hospital, Linkou, Taoyuan County, , Taiwan
Contact Details
Name: Boehringer Ingelheim
Affiliation: Boehringer Ingelheim
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
